We are live on
!
Find out more
ACM
AlphaCrest Capital Management Portfolio holdings
AUM
$1.64B
1-Year Est. Return
23.4%
This Fund
S&P 500
This Quarter
Est. Return
-7.05%
1 Year Est. Return
-23.4%
3 Year Est. Return
-8.44%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.64B
AUM Growth
-$431M
(-21%)
Cap. Flow
-$291M
Cap. Flow
% of AUM
-17.73%
Top 10 Holdings %
Top 10 Hldgs %
4.35%
Holding
1,432
New
196
Increased
495
Reduced
565
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Tower
AMT
|
+$8.3M |
| 2 |
US Bancorp
USB
|
+$8.26M |
| 3 |
Sysco
SYY
|
+$5.67M |
| 4 |
Realty Income
O
|
+$5.32M |
| 5 |
Coca-Cola
KO
|
+$5.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$17.9M |
| 2 |
Electronic Arts
EA
|
+$14M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$11M |
| 4 |
JPMorgan Chase
JPM
|
+$10.9M |
| 5 |
Amgen
AMGN
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.02% |
| 2 | Financials | 16.14% |
| 3 | Healthcare | 13.06% |
| 4 | Industrials | 12.93% |
| 5 | Consumer Discretionary | 11.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIM
1201
Chimera Investment
CIM
$1.05B
| $240K | 0.01% |
+15,347
| New | +$400K |
|
|
RCM
1202
DELISTED
R1 RCM Inc. Common Stock
RCM
| $239K | 0.01% |
12,889
+2,737
| +27% | +$62.4K |
|
1203
Buckle
BKE
$2.25B
| $238K | 0.01% |
7,527
-5,213
| -41% | -$164K |
|
1204
American Financial Group
AFG
$12B
| $236K | 0.01% |
1,916
-1,044
| -35% | -$137K |
|
1205
NVIDIA
NVDA
$4.76T
| $236K | 0.01% |
19,410
-188,080
| -91% | -$2.97M |
|
1206
Revvity
RVTY
$12.1B
| $235K | 0.01% |
1,950
-6,908
| -78% | -$974K |
|
|
DOC
1207
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $234K | 0.01% |
15,550
-15,629
| -50% | -$264K |
|
1208
Capital One
COF
$127B
| $233K | 0.01% |
2,527
-23,003
| -90% | -$2.45M |
|
1209
Globus Medical
GMED
$10.6B
| $233K | 0.01% |
3,919
-22,897
| -85% | -$1.38M |
|
1210
Laureate Education
LAUR
$5.25B
| $232K | 0.01% |
21,975
-83,069
| -79% | -$942K |
|
|
ITCI
1211
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $232K | 0.01% |
4,982
-5,253
| -51% | -$274K |
|
1212
Micron Technology
MU
$1.02T
| $229K | 0.01% |
4,561
-27,161
| -86% | -$1.58M |
|
|
VISN
1213
Vistance Networks Inc
VISN
$2.67B
| $227K | 0.01% |
24,651
-106,438
| -81% | -$1.02M |
|
1214
Q2 Holdings
QTWO
$3.64B
| $227K | 0.01% |
7,060
-5,429
| -43% | -$221K |
|
1215
Mueller Water Products
MWA
$3.94B
| $226K | 0.01% |
+21,991
| New | +$256K |
|
1216
Cannae Holdings
CNNE
$650M
| $225K | 0.01% |
+10,899
| New | +$235K |
|
|
JBTM
1217
JBT Marel
JBTM
$7.37B
| $225K | 0.01% |
2,611
+384
| +17% | +$40.7K |
|
1218
Health Catalyst
HCAT
$159M
| $224K | 0.01% |
23,060
-120,119
| -84% | -$1.59M |
|
|
SCHW
1219
Charles Schwab
SCHW
$181B
| $224K | 0.01% |
3,113
-12,147
| -80% | -$843K |
|
1220
PTC Therapeutics
PTCT
$6.29B
| $222K | 0.01% |
4,416
-4,327
| -49% | -$212K |
|
1221
Acadia Healthcare
ACHC
$2.99B
| $220K | 0.01% |
+2,817
| New | +$225K |
|
1222
National Vision
EYE
$1.66B
| $219K | 0.01% |
+6,703
| New | +$218K |
|
|
BRSL
1223
Brightstar Lottery PLC
BRSL
$1.93B
| $218K | 0.01% |
13,780
-3,614
| -21% | -$67.6K |
|
1224
Autoliv
ALV
$8.76B
| $217K | 0.01% |
3,257
-1,909
| -37% | -$148K |
|
1225
Freeport-McMoran
FCX
$90.2B
| $217K | 0.01% |
7,956
-55,675
| -87% | -$1.63M |
|
Similar funds
RHBC
BDF
SCA
IC
WFA
CA
RIG
CCP
AlphaCrest Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, AlphaCrest Capital Management held 1,432 positions worth $1.64B, down 21% from $2.07B the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
AlphaCrest Capital Management withdrew a net $291M in Q3 2022, closing 176 positions and reducing 565 holdings. Its most notable exit was Stryker, an estimated $7.96M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, AlphaCrest Capital Management opened a new position in AT&T worth $3.27M.
- AlphaCrest Capital Management's largest Q3 2022 buy was AT&T: 212,810 shares worth $3.27M.
- AlphaCrest Capital Management added most to American Tower in Q3 2022, an estimated $8.3M increase.
- AlphaCrest Capital Management's biggest Q3 2022 reduction was Target, cutting an estimated $17.9M.
- AlphaCrest Capital Management fully exited Stryker in Q3 2022, selling an estimated $7.96M.
- AlphaCrest Capital Management's ten largest holdings make up 4.4% of its $1.64B portfolio in Q3 2022.
- AlphaCrest Capital Management opened 196 new positions and closed 176 in Q3 2022.
- AlphaCrest Capital Management's portfolio value fell 21% quarter-over-quarter to $1.64B.
Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.